Today's Daily Dose brings you news about Green Growth's unsolicited take-over bid for Aphria; the stock offering of Bellerophon, PTC Therapeutics; Accuray's better-than-expected Q2 results; UNITY Biotechnology's progress in osteoarthritis trial; positive data from Ultragenyx Pharma's phase II study of UX007 in patients with long-chain fatty acid oxidation disorder.
from RTT - Biotech http://bit.ly/2DstuS2
via IFTTT
No comments:
Post a Comment